Steven S. Williamson - 02 Sep 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
PRESIDENT AND CEO, Director
Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
02 Sep 2025
Transactions value $
-$15,437
Form type
4
Filing time
03 Sep 2025, 17:14:06 UTC
Previous filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Williamson Steven S. PRESIDENT AND CEO, Director C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY /s/ David Aaron Lehman, Attorney-in-Fact 03 Sep 2025 0001478582

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$8,188 -5,118 -1.4% $1.6 363,497 02 Sep 2025 Direct F1, F2
transaction LUNG Common Stock Sale -$7,248 -4,530 -1.2% $1.6 358,967 02 Sep 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 15, 2024.
F2 Includes 2,500 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2025.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.